<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0005">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Coleman</surname>
    <given-names>C. M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>Y. V.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Mu</surname>
    <given-names>H.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Taylor</surname>
    <given-names>J. K.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Massare</surname>
    <given-names>M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Flyer</surname>
    <given-names>D. C.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Glenn</surname>
    <given-names>G. M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Smith</surname>
    <given-names>G. E.</given-names>
   </name>, &amp; 
   <name name-style="western">
    <surname>Frieman</surname>
    <given-names>M. B.</given-names>
   </name>
  </person-group> (
  <year>2014</year>). 
  <article-title>Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice</article-title>. 
  <source>
   <italic toggle="yes">Vaccine</italic>
  </source>, (
  <issue>26</issue>), 
  <fpage>3169</fpage>â€“
  <lpage>3174</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2014.04.016</pub-id>
  <pub-id pub-id-type="pmid">24736006</pub-id>
 </mixed-citation>
</ref>
